Oral Drug Delivery Resources
-
Exploring Lipid Nanoparticles For Drug Delivery
11/11/2022
Using lipid nanoparticles (LNP) for drug delivery is a promising area of research. Discover the benefits of LNP delivery, the different types of lipid nanoparticles, their safety for drug delivery, and more.
-
How Oral GLP-1 Therapies Are Revolutionizing Obesity Treatment
2/3/2025
The rising incidence and severity of obesity have amplified a therapeutic need in healthcare. Read more about Dr. Srinivasan Shanmugam discussing the challenges and impact of GLP-1 analogs.
-
A Phase I Study Allowing Clinical Screening Of Multiple Solubility-Enhancement Formulation Technologies
3/7/2022
The study was designed to assess the clinical performance of prototype formulations, assess food effect and dose linearity of a selected formulation, and the impact on exposure in subjects taking proton pump inhibitors (PPI).
-
How Approved Drugs Have Evolved Since The '70s
Drugs have become more lipophilic and complex in structure over time. Innovative strategies are needed to improve the bioavailability of these new drugs.
-
Combination Products: Market Trends And Regulatory Considerations
1/17/2024
Combination products provide significant avenues for increasing patient adherence and overall efficacy. This collection outlines the opportunity and identifies strategies for gaining regulatory approval.
-
Strategies For Accelerating The Development Of Modified Release Oral Forms
3/3/2022
Careful selection of appropriate excipients and delivery technologies is key to the design of modified release (MR) formulations fulfilling specific performance requirements.
-
Patient-Centric Formulations In Pediatric Adherence
11/13/2025
Improving pediatric adherence requires age-appropriate formulations, taste-masking, and swallowability strategies. Regulatory, clinical, and technological insights help overcome barriers and support safer, more effective therapies for children across developmental stages.
-
Combining Powdose® And Diffucaps® For Precise Solid Oral Dosing
6/30/2025
Combining POWDOSE® and Diffucaps® enables precise, individualized solid oral dosing—improving drug delivery, patient compliance, and therapeutic outcomes in personalized medicine applications.
-
Making A Case For A Fixed Dose Combination Drug Strategy
As patient-centricity spurs innovation in drug delivery systems, examine the potential of FDCs to provide convenient dosing and how increased patient compliance is alleviating the cost of health care.
-
Utilizing Nanoparticle Technologies For A More Sustainable Value Chain
The pharma industry is identifying ways to make processes more sustainable. Learn how nanoparticle engineering technology can both empower sustainability goals and lead to better patient outcomes.